pharma
#biotech
pharma
Two Biotech Heavyweights Sign On to China's Haisco
pharma
Pfizer Exec Says China's Biotech Boom Is About to Get Harder
pharma
Senate Picks Up BINSA, the Bill Aimed at Choking Off US-China Biotech Deals
pharma
Dash Bio Lands $30M Series A for a Pitch Investors Didn't Want to Hear
pharma
BioNTech Taps Sobi Chief Guido Oelkers as Its Next CEO
pharma
After 37 Years, Ionis' Founding Scientist Frank Bennett Is Stepping Away
pharma
Novo Nordisk's Heart Drug Flunks Phase 3, Denting a Whole Theory of Heart Disease
tech
China's 'Next New Three': AI, Robots and New Drugs Take Center Stage
pharma
UK Biotech Funding Roars Back to a Record in Q2 2026
pharma
AI-Designed Drugs Face Their First Real Test: the Clinic
pharma
Jasper Finds a Lifeline in Merger With Immune Drugmaker Kira
pharma
AI Is Reshaping How Pharma Runs Clinical Trials
pharma
Kalshi Opens Betting on Drug Trial Outcomes and FDA Decisions
pharma
Secretive Mirador Lifts the Veil on a Drug Licensed From Kira
pharma
Biotech's VC Rebound Is Leaving the Smallest Startups Behind
pharma
Insilico and CMS Deepen AI Drug Push With Brain-Disease Deal Worth Up to $2.5bn
pharma
Generative AI Is Rewriting the Drug Discovery Playbook
pharma
Reed Jobs Bets on Cancer Cures as His Biotech Fund Yosemite Scales Up
pharma
Nvidia's Jensen Huang Bets AI's Biggest Payoff Won't Be in Chips — It'll Be in Medicine
pharma
Recursion Pharmaceuticals Draws Fresh Scrutiny Over Its Biotech AI Bet
pharma
Apnimed Files for Nasdaq IPO as FDA Weighs Its Sleep Apnea Drug
pharma
US Government Bets $160M on One-of-a-Kind Gene Editing Cures
pharma
Anthropic's CEO Weighs In on What AI Could Mean for Biotech
pharma
Recursion's AI Drug Bet Hasn't Won Over the Stock Market
pharma
AI Moves Into Drug Discovery, and Investors Smell a Trillion-Dollar Prize
pharma
Scribe Therapeutics Files for IPO, Testing Wall Street's Taste for Early-Stage Biotech
pharma
Takeda Bets on AI, Signs Drug Discovery Deal With Insilico Worth Up to $600 Million
defense
China's AI Drug-Design Deals Boom Even as US Scrutiny Grows
pharma
Biotech Megarounds Rebound as 40 Startups Land $100M+ in Early 2026
pharma
AI Moves From Buzzword to Deal-Maker in Drug Discovery
pharma
AI Is Compressing Drug Discovery From Years to Weeks
pharma
Evommune's Lead Hives Drug Fails Phase 3, Stock Sinks Over 30%
pharma
Zymeworks Buys Struggling Theravance in $929M Royalty Play
pharma
AI Scientist Firm Edison Teams With Metsera Backers to Spawn New Biotechs
pharma
Metsera's Founders Bet on an 'AI Scientist' to Spin Up New Biotechs
pharma
Machine Learning Aims to Rewrite Life's Genetic Code for Biotech
pharma
Biotech's Top Lobbyist Pitches a Single Playbook for AI, Rules and National Security
pharma
Boehringer Bets $15M on Immunai's AI to Hunt Cancer Drug Targets
pharma
Epicrispr Turns to 'Digital Twins' to Test a Muscle Disease Therapy
pharma
Biotech IPO Window Cracks Open — But Only for a Chosen Few
pharma
Insilico Inks AI Drug Discovery Pact Worth Up to $2.5 Billion
pharma
HHS Launches Sweeping Push to Speed Up Clinical Trials
defense
In Washington's China Biotech Fight, the Hawks Are the Loudest Voices
pharma
AI's Next Act in Medicine Could Mint a New Class of Millionaires
pharma
AI-Designed Vaccine Clears Its First Human Trial
pharma
India Eyes the Biotech Ground America Is Leaving Behind
pharma
Biotech Leaders Navigate AI Drug Discovery Amid Funding and Regulatory Shifts
pharma
RA Capital, Forbion and Sanofi Ventures Back New Korean Eye Drug
defense
US Treasury Eyes New Curbs on Investing in China Biotech
pharma
Eli Lilly's TuneLab AI Program Crosses 100 Members, Adds Chai's Models
pharma
Washington Post Spotlights China's Growing Biotech Dominance in the AI Era
pharma
Vedana Therapeutics Launches With $46M to Chase a Migraine Cure
pharma
AI Is Running Fake Clinical Trials — and Finding Real Drug Candidates
pharma
Lilly Snaps Up Non-Opioid Pain Startup in Latest Dealmaking Push
pharma
Neumora's Depression Drug Fails, Casting Shadow Over a Promising Brain Drug Class
pharma
Merck Bets on AI Drug Design With Protillion Biosciences Deal
pharma
Insilico Medicine Launches 'Bits to Bio' Series on AI-Drug Discovery
pharma
Radical Numerics Emerges With $50M to Crack the Code of Life Using AI
pharma
Lilly's $2.3B Bet on Blood Cancer Drug Pays Off Early
pharma
Pharma's Billion-Dollar AI Bet Is Reshaping Drug Discovery
pharma
Neumora's Depression Drug Fails Again — Taking 35% of the Workforce With It
pharma
From Lab to Factory Floor: AI's Next Big Pharma Challenge
pharma
Australia's First AI-Designed Vaccine Trial Points to a New Era of Pandemic Readiness
pharma
HMNC Brain Health Lands $50M to Push Two Depression Drugs Into Mid-Stage Trials
pharma
AI Drug Discovery Is Booming — But Hurdles Remain
pharma
AI and Cell Painting Are Quietly Rewriting How New Drugs Get Made
pharma
Insilico Medicine Signs $888M AI Cancer Drug Deal With Servier Days After Hong Kong IPO
pharma
Eli Lilly Bets Up to $2.75 Billion on AI-Designed Drugs in Insilico Medicine Deal
pharma
Insilico Medicine Bets on Aging With Industry's First Longevity Board
pharma
Pfizer Bets on AI Startup Chai Discovery to Speed Up Drug Search
pharma
AI Drug Discovery Is Booming — But Can It Deliver in the Clinic?
ai